Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix in Hepatitis B Vaccine Non-Responders
NCT03410953Phase 4Completed
- Sponsor
- Fundación Instituto de Ciencias de la Salud de Castilla y León
- Start
- Apr 2018
- Primary completion
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Fundación Instituto de Ciencias de la Salud de Castilla y León. Started Apr 2018; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03410953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410953.